See It Market
31 Oct 2025, 19:43 UTC · 45w ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Analysis by Kasper Rasmussen · Founder & analyst
Which stocks this story touches
The ETF is described as being 'on a tear' and reaching multi-year highs with a reasonable upside target.
Stock rose 17% on reports of potential deal talks and is described as having an interesting chart.
Identified as a top company and noted for heavily investing in AI to enhance R&D.
Positive news regarding a landmark agreement with the administration and the acquisition of Metsera.
Described as a leader in the biofuel space.
Continue reading
5 related stories
Top 1 mover · tap to explore
Mentioned as one of the top companies in the medical and pharmaceutical biotech space.
Listed as a promising company in the rapidly evolving area of gene editing.
Listed as a promising company in AI-powered drug discovery.
Mentioned as having lost a bidding war to Pfizer for the acquisition of Metsera.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Seeking Alpha
12h ago
